Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Express Scripts
UBS
US Army
Mallinckrodt
AstraZeneca
McKinsey
US Department of Justice
Harvard Business School

Generated: October 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090902

« Back to Dashboard

NDA 090902 describes CLINDAMYCIN PALMITATE HYDROCHLORIDE, which is a drug marketed by Amneal Pharms, Aurobindo Pharma Ltd, Heritage Pharms Inc, Lyne, Mylan Pharms Inc, Orit Labs Llc, and Paddock Llc, and is included in seven NDAs. It is available from nine suppliers. Additional details are available on the CLINDAMYCIN PALMITATE HYDROCHLORIDE profile page.

The generic ingredient in CLINDAMYCIN PALMITATE HYDROCHLORIDE is clindamycin palmitate hydrochloride. There are fifty-five drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for 090902
Tradename:CLINDAMYCIN PALMITATE HYDROCHLORIDE
Applicant:Paddock Llc
Ingredient:clindamycin palmitate hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 090902
Ingredient-typeLincosamides
Physiological EffectDecreased Sebaceous Gland Activity
Suppliers and Packaging for NDA: 090902
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLINDAMYCIN PALMITATE HYDROCHLORIDE clindamycin palmitate hydrochloride FOR SOLUTION;ORAL 090902 ANDA Paddock Laboratories, LLC 0574-0129 0574-0129-01 1 BOTTLE, GLASS in 1 CARTON (0574-0129-01) > 100 mL in 1 BOTTLE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SOLUTION;ORALStrengthEQ 75MG BASE/5ML
Approval Date:Jul 7, 2010TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Federal Trade Commission
Queensland Health
Harvard Business School
Teva
Accenture
Cantor Fitzgerald
Cipla
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.